A Clinical Trial to Investigate the Effect of a Short Duration Infusion of Obinutuzumab in Patients with Previously Untreated Advanced Follicular Lymphoma (MO40597 study)
An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma (MO40597 study)
-
Cancer -
Non Hodgkin Lymphoma (NHL) -
Follicular Lymphoma
For the latest version of this information please go to www.forpatients.roche.com